Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells

Molecular Endocrinology

Volumn 10, Issue 5, 1996, Pages 488-498

  Foster, James S ^a   Wimalasena, Jay ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ESTRADIOL; FULVESTRANT; RETINOBLASTOMA PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA SYNTHESIS; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; GROWTH REGULATION; GROWTH STIMULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CYCLIN B; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA; ENZYME ACTIVATION; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; G1 PHASE; HUMANS; ONCOGENE PROTEINS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR CELLS, CULTURED;

EID: 0030012189     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.10.5.488     Document Type: Article

References (84)

1. Pearson OH, West DC, Hollander VP, Treves NE 1954 Evaluation of endocrine therapy for advanced breast cancer. J Am Med Assoc 154:234-239
2. Lippman ME, Dickson RB 1989 Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res 45:383-440
3. Santen RJ, Manni A, Harvey H, Redmond C 1990 Endocrine treatment of breast cancer in women. Endocr Rev 11:221-265
4. Lippman ME, Bolan G 1975 Oestrogen-responsive human breast cancer in long term tissue culture. Nature 256:592-593
5. Lippman M, Bolan G, Huff K 1976 The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture. Cancer Res 36:4595-4601
6. Lippman M, Monaco ME, Bolan G 1977 Effects of estrone, estradiol and estriol on hormone responsive human breast cancer in long term tissue culture. Cancer Res 37:1901-1907
7. 1 phase of the cell cycle. Eur J Cancer Clin Oncol 19:615-621
8. Sutherland RL, Hall RE, Taylor IW 1983 Cell proliferation kinetics of MCF7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res 43:3998-4006
9. Taylor IW, Hodson PJ, Green MD, Sutherland RL 1983 Effects of tamoxifen on cell cycle progression of synchronous MCF7 human mammary carcinoma cells. Cancer Res 43:4007-4010
10. Wakeling AE, Newboult E, Peters SW 1989 Effects of antioestrogens on the proliferation of MCF7 human breast cancer cells. J Mol Endocrinol 2:225-234
11. Manni A, Pearson OH 1982 Antioestrogens in tumour therapy. Clin Oncol 1:65-75
12. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
13. Osborne CK, Arteaga CL 1990 Autocrine and paracrine growth regulation of breast cancer: clinical implications. Breast Cancer Res Treat 15:3-11
14. Arteaga CL, Osborne CK 1991 Growth factors as mediators of estrogen/antiestrogen action in human breast cancer cells. In: Lippman M, Dickson R (ed) Regulatory Mechanisms in Breast Cancer. Kluewer Academic Publishers, Boston, MA, pp 289-304
15. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachian JA, Korach KS 1992 Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
16. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachian JS 1993 Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992-998
17. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto V, Stalla GK 1994 The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem 48: 481-486
18. Phillips A, Chalbos D, Rochefort H 1993 Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. J Biol Chem 268:14103-14108
19. Musgrove EA, Hamilton JA, Lee CSL, Sweeney KJE, Watts CKW, Sutherland RL 1993 Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13:3577-3587
20. Musgrove EA, Sutherland RL 1993 Effects of the progestin antagonist RU486 on T-47D cell proliferation. Biochem Biophys Res Commun 146:1184-1190
21. Vignon F, Bouton MM, Rochefort H 1987 Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502-1508
22. 1 gene expression in MCF7 human breast cancer cells. Breast Cancer Res Treat 31:95-105
23. Schuchard M, Lander JP, Sanohu NP, Spelsberg TC 1993 Steroid hormone regulation of nuclear proto-oncogenes. Endocr Rev 14:659-669
24. Sherr CJ 1993 Mammalian G1 cyclins. Cell 73:1059-1065
25. Sherr CJ 1994 G1 phase progression: cycling on cue. Cell 79:551-555
26. PSK-J3/Cdk4) for mammalian D type G1 cyclins. Cell 71:323-334
27. Meyerson M, Harlow E 1994 Identification of G1 kinase activity for Cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077-2086
28. Dulic V, Lees E, Reed SI 1992 Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:2907-2911
29. Koff A, Ohtsubo M, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza R, Roberts JM 1992 Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694
30. Elledge SJ, Richman R, Hall FL, Williams RT, Lodgson N, Harper JW 1992 CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc Natl Acad Sci USA 89:2907-2911
31. Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G 1993 Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 121:101-111
32. Rosenblatt J, Gu Y, Morgan DO 1992 Human cyclin-dependent kinase 2 (CDK2) is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci USA 89:2824-2828
33. Gu Y, Rosenblatt J, Morgan DO 1992 Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 11:3995-4005
34. Kato JY, Matsuoka M, Strom DK, Sherr CJ 1994 Regulation of cyclin D-dependent kinase 4 (Cdk4) by Cdk4-activating kinase. Mol Cell Biol 14:2713-2721
35. Tsai L, Lees E, Faha B, Harlow E, Riabowol K 1993 The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8:1593-1602
36. Cao L, Faha B, Dembski M, Harlow LH, Dyson N 1992 Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176-179
37. Devoto SH, Mudryi M, Pines J, Hunter T, Nevins J 1992 A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex. Cell 68:167-176
38. Lees E, Faha B, Dulic V, Reed SI, Harlow E 1992 Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6:1874-1885
39. Pagano M, Draetta G, Jansen-Durr P 1992 Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255:1144-1147
40. Akiyama T, Ohuchu T, Sumida S, Matsumoto K, Toyoshima K 1992 Phosphorylation of the retinoblastoma protein by cdk2. Proc Natl Acad Sci USA 89:7900-7904
41. Dynlacht BD, Flores O, Lees JA, Harlow E 1994 Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev 8:1772-1786
42. Hids P, Mittnacht S, Dulic V, Arnold A, Reed S, Weinberg R 1992 Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006
43. Cobrinik D, Dowdy P, Hinds P, Mittnacht S, Weinberg R 1992 The retinoblastoma protein and the regulation of the cell-cycling. Trends Biochem Soc 17:312-315
44. Sutherland RL, Reddel RR, Green MD 1983 Effects of oestrogens on cell proliferation and cell cycle kinetics: a hypothesis on the cell cycle effects of antioestrogen. Eur J Cancer Clin Onol 19:307-318
45. 1 phase population. J Cell Biochem 34:213-225
46. Reddel RR, Murphy LC, Sutherland RL 1984 Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res 44:2398-2405
47. 1 protein oscillates and is essential for cell cycle progression in human tumor cells. Oncogene 9:707-717
48. 1 to complete the cell cycle. Proc Natl Acad Sci USA 91:8022-8026
49. Thomas T, Thomas TJ 1994 Regulation of cyclin B1 by estradiol and polyamines in MCF7 breast cancer cells. Cancer Res 54:1077-1084
50. Gudas JM, Nguyen H, Li T, Cowan KH 1995 Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55:4561-4565
51. Wimalasena J, Meehan D, Cavallo C 1991 Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins. Gynecol Oncol 41:56-63
52. Wimalasena J, Dostal R, Meehan D 1992 Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 46:345-350
53. Wimalasena J, Meehan D, Dostal R, Foster JS, Cameron M, Smith M 1993 Growth factors interact with estradiol and gonadotropins in the regulation of ovarian cancer cell growth and growth factor receptors. Oncol Res 5:325-337
54. Sherr CJ, Roberts JM 1995 Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
55. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY 1994 D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076
56. Ohtsubo M, Theodoras AM, Schumachen J, Roberts JM, Pagano M 1995 Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624
57. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ 1993 The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
58. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66
59. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MF, Reed SI 1994 A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 14:3683-3694
60. Toyoshima H, Hunter T 1994 p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74
61. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D 1993 p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
62. Firpo EJ, Koff A, Solomon MJ, Roberts JM 1994 Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14: 4889-4901
63. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22
64. kip-1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573
65. kip-1) of cyclin-dependent kinase-4 activation. Cell 79:487-496
66. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB, Lippman ME 1988 Differential regulation of growth and invasiveness of MCF7 breast cancer cells by antiestrogens. Cancer Res 48:6784-6768
67. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51: 3867-3873
68. Webb P, Lopez GN, Uht RM, Kusher PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
69. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts DKW, Musgrove EA, Sutherland RL 1993 Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133
70. Keyomarsi K, Pardee AB 1993 Redundant cyclin over-expression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:112-116
71. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA 1995 Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630
72. 1-to-S transition. Mol Cell Biol 15:3463-3469
73. 1 control in retinoblastoma gene-deficient cells independently of Cdk4 activity. Mol Cell Biol 15:2600-2611
74. 1 promoter. Oncogene 9:1295-1304
75. Krishnan V, Wang X, Safe S 1994 Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem 269:15912-15917
76. kip-1. Mol Cell Biol 15:4347-4352
77. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M 1995 Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685
78. Watts CKW, Brady A, Sarcevic B, deFazio A, Musgrove EA, Sutherland RL 1995 Antiestrogen inhibition of cell cycle progression in breast cancer cells is associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation. Mol Endocrinol 9:1804-1813
79. Page MJ, Field JK, Everett NP, Green CD 1983 Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 43:1244-1250
80. Barnes DW 1984 Serum-free cell culture of MCF-7 human mammary carcinoma. In: Barnes DW, Sirbask DA, Sato GH (eds) Methods for Serum-Free Culture of Cells of the Endocrine System. Alan R. Liss Inc., New York, NY, pp 201-216
81. van der Burg B, Rutteman GR, Blankenship MA, deLaat S, van Zoelen EJJ 1988 Mitogenic stimulation of human breast cancer cells in a growth factor- defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134:101-108
82. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS 1986 Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
83. Mittnacht S, Weinberg RA 1991 G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear component. Cell 65:381-393
84. Bradford M 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254